Menthol Regulation for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how different types of cigarettes and e-cigarettes affect smoking behavior, especially with menthol. Researchers will assign participants to use either menthol or non-menthol cigarettes and e-cigarettes for eight weeks to simulate potential menthol regulation. The goal is to determine if these changes help people smoke less or quit, particularly during the final week when smoking cessation is incentivized. Ideal participants are adults who have smoked at least five menthol cigarettes daily for over a year and own a smartphone for daily diary entries.
As an unphased trial, this study offers a unique opportunity to contribute to important research that could influence future smoking regulations.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the FDA has approved menthol and tobacco-flavored e-cigarettes, indicating they have passed strict safety checks. Studies suggest menthol e-cigarettes might help reduce the urge to smoke, but caution is advised. Some research using a vaping machine found that menthol might increase harmful particles inhaled, potentially affecting lung health.
Tobacco-flavored e-cigarettes typically contain fewer harmful chemicals than regular cigarettes. However, using both cigarettes and e-cigarettes can increase the risk of health issues, such as lung cancer.
In summary, while e-cigarettes may be safer than regular cigarettes, they still carry risks. Consider the potential health effects when deciding to join a trial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different forms of menthol and non-menthol tobacco products might help with smoking cessation. Unlike the standard options like nicotine replacement therapies or medications such as varenicline, this trial looks at whether adjusting the type of cigarette or e-cigarette could aid in quitting smoking. By comparing menthol and non-menthol cigarettes and e-cigarettes, the trial aims to uncover how these variations impact smoking habits and potentially offer new strategies for those looking to quit. This approach is unique because it shifts the focus from pharmaceutical interventions to behavioral and sensory factors in smoking cessation.
What evidence suggests that this trial's treatments could be effective for smoking cessation?
Research has shown that menthol cigarettes can make quitting smoking more difficult. Studies have found that people who smoke menthol cigarettes often struggle more to quit than those who smoke regular cigarettes. Menthol cigarettes are also considered more addictive. This trial will explore different combinations of menthol and non-menthol products. Participants in one arm will receive menthol spectrum cigarettes and menthol e-cigarettes, while another arm will receive non-menthol spectrum cigarettes and menthol e-cigarettes. Other arms will test combinations of menthol spectrum cigarettes with tobacco e-cigarettes, and non-menthol spectrum cigarettes with tobacco e-cigarettes. Some research suggests that e-cigarettes, in general, can help people quit smoking more effectively than traditional methods. However, the impact of menthol versus tobacco flavors in e-cigarettes on smoking habits remains unclear.678910
Are You a Good Fit for This Trial?
This trial is for adults over 21 who regularly smoke menthol cigarettes, use a specific brand most often, and have been smoking at least 5 cigarettes daily for one year. Participants must own a smartphone capable of receiving texts and internet access to complete diaries.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a baseline period before being assigned to a cigarette and e-cigarette condition
Treatment
Participants receive a 7-week supply of cigarettes and e-cigarettes and are instructed to only use their assigned products
Practice Quit Attempt
Participants are incentivized to abstain from smoking during Week 7, with continued e-cigarette use allowed
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Menthol Cigarettes
- Menthol Flavored E-cigarettes
- Non-Menthol Cigarettes
- Tobacco Flavored E-cigarettes
Menthol Cigarettes is already approved in European Union, United States, Canada, Brazil for the following indications:
- Not approved due to ban on menthol cigarettes
- Not approved due to proposed ban on menthol cigarettes
- Not approved due to ban on menthol cigarettes
- Not approved due to ban on menthol cigarettes
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
University of Minnesota
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator